This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
LA Adler , R Edson , P Lavori , E Peselow , E Duncan , M Rosenthal , J Rotrosen (1998). Long-term treatment effects of vitamin E for tardive dyskinesia. Biological Psychiatry 43, 868–872.
LA Adler , J Rotrosen , R Edson , P Lavori , J Lohr , R Hitzemann , D Raisch , M Caligiuri , K Tracy (1999). Vitamin E treatment for tardive dyskinesia. Veterans Affairs Cooperative Study #394 Study Group. Archives of General Psychiatry 56, 836–841.
O Akyol , H Herken , E Uz , E Fadillioglu , S Unal , S Sogut , H Ozyurt , HA Savas (2002). The indices of endogenous oxidative and antioxidative processes in plasma from schizophrenic patients. The possible role of oxidant/antioxidant imbalance. Progress in Neuropsychopharmacology and Biological Psychiatry 26, 995–1005.
O Akyol , M Yanik , H Elyas , M Namli , H Canatan , H Akin , H Yuce , HR Yilmaz , H Tutkun , S Sogut , (2005). Association between Ala-9Val polymorphism of Mn-SOD gene and schizophrenia. Progress in Neuropsychopharmacology and Biological Psychiatry 29, 123–131.
I Altuntas , H Aksoy , I Coskun , A Caykoylu , F Akcay (2000). Erythrocyte superoxide dismutase and glutathione peroxidase activities, and malondialdehyde and reduced glutathione levels in schizophrenic patients. Clinical Chemistry and Laboratory Medicine 38, 1277–1281.
R Amanvermez , E Agara (2006). Does ascorbate/L-Cys/L-Met mixture protect different parts of the rat brain against chronic alcohol toxicity? Advances in Therapy 23, 705–718.
OA Andreassen , HA Jorgensen (2000). Neurotoxicity associated with neuroleptic-induced oral dyskinesias in rats. Implications for tardive dyskinesia? Progress in Neurobiology 61, 525–541.
AC Andreazza , C Cassini , AR Rosa , MC Leite , LM de Almeida , P Nardin , AB Cunha , KM Cereser , A Santin , C Gottfried , (2007). Serum S100B and antioxidant enzymes in bipolar patients. Journal of Psychiatric Research 41, 523–529.
L Arranz , N Guayerbas , M De la Fuente (2007). Impairment of several immune functions in anxious women. Journal of Psychosomatic Research 62, 1–8.
M Arvindakshan , M Ghate , PK Ranjekar , DR Evans , SP Mahadik (2003a). Supplementation with a combination of omega-3 fatty acids and antioxidants (vitamins E and C) improves the outcome of schizophrenia. Schizophrenia Research 62, 195–204.
M Arvindakshan , S Sitasawad , V Debsikdar , M Ghate , D Evans , DF Horrobin , C Bennett , PK Ranjekar , SP Mahadik (2003b). Essential polyunsaturated fatty acid and lipid peroxide levels in never-medicated and medicated schizophrenia patients. Biological Psychiatry 53, 56–64.
KR Atkuri , JJ Mantovani , LA Herzenberg , LA Herzenberg (2007). N-Acetylcysteine-a safe antidote for cysteine/glutathione deficiency. Current Opinion in Pharmacology 7, 355–359.
M Atmaca , E Tezcan , M Kuloglu , B Ustundag , O Kirtas (2005). The effect of extract of ginkgo biloba addition to olanzapine on therapeutic effect and antioxidant enzyme levels in patients with schizophrenia. Psychiatry and Clinical Neurosciences 59, 652–656.
M Atmaca , E Tezcan , M Kuloglu , B Ustundag , H Tunckol (2004). Antioxidant enzyme and malondialdehyde values in social phobia before and after citalopram treatment. European Archives of Psychiatry and Clinical Neuroscience 254, 231–235.
A Azzi (2007). Molecular mechanism of alpha-tocopherol action. Free Radical Biology and Medicine 43, 16–21.
DA Baker , K McFarland , RW Lake , H Shen , S Toda , PW Kalivas (2003). N-acetyl cysteine-induced blockade of cocaine-induced reinstatement. Annals of the New York Academy of Sciences 1003, 349–351.
KJ Barnham , CL Masters , AI Bush (2004). Neurodegenerative diseases and oxidative stress. Nature Reviews. Drug Discovery 3, 205–214.
FM Benes , D Matzilevich , RE Burke , J Walsh (2006). The expression of proapoptosis genes is increased in bipolar disorder, but not in schizophrenia. Molecular Psychiatry 11, 241–251.
M Berk , W Bodemer , T Van Oudenhove , N Butkow (1995). The platelet intracellular calcium response to serotonin is augmented in bipolar manic and depressed patients. Human Psychopharmacology 10, 189–193.
M Berk , NH Kirchmann , N Butkow (1996). Lithium blocks 45Ca2+ uptake into platelets in bipolar affective disorder and controls. Clinical Neuropharmacology 19, 48–51.
M Bilici , H Efe , MA Koroglu , HA Uydu , M Bekaroglu , O Deger (2001). Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments. Journal of Affective Disorders 64, 43–51.
LA Boothby , PL Doering (2005). Vitamin C and vitamin E for Alzheimer's disease. Annals of Pharmacotherapy 39, 2073–2080.
J Bouayed , H Rammal , A Dicko , C Younos , R Soulimani (2007a). Chlorogenic acid, a polyphenol from Prunus domestica (Mirabelle), with coupled anxiolytic and antioxidant effects. Journal of the Neurological Sciences 262, 77–84.
J Bouayed , H Rammal , C Younos , R Soulimani (2007b). Positive correlation between peripheral blood granulocyte oxidative status and level of anxiety in mice. European Journal of Pharmacology 564, 146–149.
TD Buckman , AS Kling , S Eiduson , MS Sutphin , A Steinberg (1987). Glutathione peroxidase and CT scan abnormalities in schizophrenia. Biological Psychiatry 22, 1349–1356.
AS Chan , LW Ng , LS Poon , WW Chan , YH Wong (2007). Dopaminergic and adrenergic toxicities on SK-N-MC human neuroblastoma cells are mediated through G protein signaling and oxidative stress. Apoptosis 12, 167–179.
A Chauhan , V Chauhan , WT Brown , I Cohen (2004). Oxidative stress in autism: increased lipid peroxidation and reduced serum levels of ceruloplasmin and transferrin–the antioxidant proteins. Life Sciences 75, 2539–2549.
B Chen , JF Wang , LT Young (2000). Chronic valproate treatment increases expression of endoplasmic reticulum stress proteins in the rat cerebral cortex and hippocampus. Biological Psychiatry 48, 658–664.
G Chen , WZ Zeng , PX Yuan , LD Huang , YM Jiang , ZH Zhao , HK Manji (1999). The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS. Journal of Neurochemistry 72, 879–882.
J Chen , C Wersinger , A Sidhu (2003). Chronic stimulation of D1 dopamine receptors in human SK-N-MC neuroblastoma cells induces nitric-oxide synthase activation and cytotoxicity. Journal of Biological Chemistry 278, 28089–28100.
Z Chovanova , J Muchova , M Sivonova , M Dvorakova , I Zitnanova , I Waczulikova , J Trebaticka , I Skodacek , Z Durackova (2006). Effect of polyphenolic extract, Pycnogenol, on the level of 8-oxoguanine in children suffering from attention deficit/hyperactivity disorder. Free Radical Research 40, 1003–1010.
J Cui , L Shao , LT Young , JF Wang (2007). Role of glutathione in neuroprotective effects of mood stabilizing drugs lithium and valproate. Neuroscience 144, 1447–1453.
G Dakhale , S Khanzode , S Khanzode , A Saoji , L Khobragade , A Turankar (2004). Oxidative damage and schizophrenia: the potential benefit by atypical antipsychotics. Neuropsychobiology 49, 205–209.
GN Dakhale , SD Khanzode , SS Khanzode , A Saoji (2005). Supplementation of vitamin C with atypical antipsychotics reduces oxidative stress and improves the outcome of schizophrenia. Psychopharmacology 182, 494–498.
KJ Davies (1995). Oxidative stress: the paradox of aerobic life. Biochemical Society Symposium 61, 1–31.
KJ Davies (2000). Oxidative stress, antioxidant defenses, and damage removal, repair, and replacement systems. IUBMB Life 50, 279–289.
MR de Oliveira , RB Silvestrin , EST Mello , JC Moreira (2007). Oxidative stress in the hippocampus, anxiety-like behavior and decreased locomotory and exploratory activity of adult rats: effects of sub acute vitamin A supplementation at therapeutic doses. Neurotoxicology 28, 1191–1199.
AP de Vasconcellos , FB Nieto , LM Crema , LA Diehl , LM de Almeida , ME Prediger , ER da Rocha , C Dalmaz (2006). Chronic lithium treatment has antioxidant properties but does not prevent oxidative damage induced by chronic variate stress. Neurochemical Research 31, 1141–1151.
A Dietrich-Muszalska , B Olas , J Rabe-Jablonska (2005). Oxidative stress in blood platelets from schizophrenic patients. Platelets 16, 386–391.
JB Dietrich , A Mangeol , MO Revel , C Burgun , D Aunis , J Zwiller (2005). Acute or repeated cocaine administration generates reactive oxygen species and induces antioxidant enzyme activity in dopaminergic rat brain structures. Neuropharmacology 48, 965–974.
KQ Do , CJ Lauer , W Schreiber , M Zollinger , U Gutteck-Amsler , M Cuenod , F Holsboer (1995). gamma-Glutamylglutamine and taurine concentrations are decreased in the cerebrospinal fluid of drug-naive patients with schizophrenic disorders. Journal of Neurochemistry 65, 2652–2662.
KQ Do , AH Trabesinger , M Kirsten-Kruger , CJ Lauer , U Dydak , D Hell , F Holsboer , P Boesiger , M Cuenod (2000). Schizophrenia: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo. European Journal of Neuroscience 12, 3721–3728.
K Drieu , R Vranckx , C Benassayad , M Haourigi , J Hassid , RG Yoa , JR Rapin , EA Nunez (2000). Effect of the extract of Ginkgo biloba (EGb 761) on the circulating and cellular profiles of polyunsaturated fatty acids: correlation with the anti-oxidant properties of the extract. Prostaglandins, Leukotrienes, and Essential Fatty Acids 63, 293–300.
M Dvorakova , M Sivonova , J Trebaticka , I Skodacek , I Waczulikova , J Muchova , Z Durackova (2006). The effect of polyphenolic extract from pine bark, Pycnogenol on the level of glutathione in children suffering from attention deficit hyperactivity disorder (ADHD). Redox Report 11, 163–172.
I Eren , M Naziroglu , A Demirdas (2007a). Protective effects of lamotrigine, aripiprazole and escitalopram on depression-induced oxidative stress in rat brain. Neurochemical Research 32, 1188–1195.
S Ersan , S Bakir , E Erdal Ersan , O Dogan (2006). Examination of free radical metabolism and antioxidant defence system elements in patients with obsessive-compulsive disorder. Progress in Neuropsychopharmacology and Biological Psychiatry 30, 1039–1042.
U Ettinger , M Picchioni , S Landau , K Matsumoto , NE van Haren , N Marshall , MH Hall , K Schulze , T Toulopoulou , N Davies , (2007). Magnetic resonance imaging of the thalamus and adhesio interthalamica in twins with schizophrenia. Archives of General Psychiatry 64, 401–409.
DR Evans , VV Parikh , MM Khan , C Coussons , PF Buckley , SP Mahadik (2003). Red blood cell membrane essential fatty acid metabolism in early psychotic patients following antipsychotic drug treatment. Prostaglandins, Leukotrienes, and Essential Fatty Acids 69, 393–399.
G Filomeni , MR Ciriolo (2006). Redox control of apoptosis: an update. Antioxidants and Redox Signaling 8, 2187–2192.
T Finkel , NJ Holbrook (2000). Oxidants, oxidative stress and the biology of ageing. Nature 408, 239–247.
MJ Forlenza , GE Miller (2006). Increased serum levels of 8-hydroxy-2'-deoxyguanosine in clinical depression. Psychosomatic Medicine 68, 1–7.
BN Frey , AC Andreazza , M Kunz , FA Gomes , J Quevedo , M Salvador , CA Goncalves , F Kapczinski (2007). Increased oxidative stress and DNA damage in bipolar disorder: a twin-case report. Progress in Neuropsychopharmacology and Biological Psychiatry 31, 283–285.
BN Frey , MR Martins , FC Petronilho , F Dal-Pizzol , J Quevedo , F Kapczinski (2006a). Increased oxidative stress after repeated amphetamine exposure: possible relevance as a model of mania. Bipolar Disorders 8, 275–280.
BN Frey , SS Valvassori , KM Gomes , MR Martins , F Dal-Pizzol , F Kapczinski , J Quevedo (2006b). Increased oxidative stress in submitochondrial particles after chronic amphetamine exposure. Brain Research 1097, 224–229.
BN Frey , SS Valvassori , GZ Reus , MR Martins , FC Petronilho , K Bardini , F Dal-Pizzol , F Kapczinski , J Quevedo (2006c). Changes in antioxidant defense enzymes after d-amphetamine exposure: implications as an animal model of mania. Neurochemical Research 31, 699–703.
G Fukami , K Hashimoto , K Koike , N Okamura , E Shimizu , M Iyo (2004). Effect of antioxidant N-acetyl-L-cysteine on behavioral changes and neurotoxicity in rats after administration of methamphetamine. Brain Research 1016, 90–95.
K Fukunaga , M Yoshida , N Nakazono (1998). A simple, rapid, highly sensitive and reproducible quantification method for plasma malondialdehyde by high-performance liquid chromatography. Biomedical Chromatography 12, 300–303.
CS Gama , M Salvador , AC Andreazza , F Kapczinski , Belmonte-de-Abreu P Silva (2006). Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in schizophrenia: a study of patients treated with haloperidol or clozapine. Progress in Neuropsychopharmacology and Biological Psychiatry 30, 512–515.
HS Gergerlioglu , HA Savas , F Bulbul , S Selek , E Uz , M Yumru (2007). Changes in nitric oxide level and superoxide dismutase activity during antimanic treatment. Progress in Neuropsychopharmacology and Biological Psychiatry 31, 697–702.
DC Goff , JT Coyle (2001). The emerging role of glutamate in the pathophysiology and treatment of schizophrenia. American Journal of Psychiatry 158, 1367–1377.
R Gysin , R Kraftsik , J Sandell , P Bovet , C Chappuis , P Conus , P Deppen , M Preisig , V Ruiz , P Steullet , (2007). Impaired glutathione synthesis in schizophrenia: convergent genetic and functional evidence. Proceedings of the National Academy of Sciences USA 104, 16621–16626.
B Halliwell (2006). Oxidative stress and neurodegeneration: where are we now? Journal of Neurochemistry 97, 1634–1658.
NC Hansen , A Skriver , L Brorsen-Riis , S Balslov , T Evald , N Maltbaek , G Gunnersen , P Garsdal , P Sander , JZ Pedersen , (1994). Orally administered N-acetylcysteine may improve general well-being in patients with mild chronic bronchitis. Respiratory Medicine 88, 531–535.
S Hayley , MO Poulter , Z Merali , H Anisman (2005). The pathogenesis of clinical depression: stressor- and cytokine-induced alterations of neuroplasticity. Neuroscience 135, 659–678.
U Hemmeter , B Annen , R Bischof , U Bruderlin , M Hatzinger , U Rose , E Holsboer-Trachsler (2001). Polysomnographic effects of adjuvant ginkgo biloba therapy in patients with major depression medicated with trimipramine. Pharmacopsychiatry 34, 50–59.
H Herken , A Gurel , S Selek , F Armutcu , ME Ozen , M Bulut , O Kap , M Yumru , HA Savas , O Akyol (2007). Adenosine deaminase, nitric oxide, superoxide dismutase, and xanthine oxidase in patients with major depression: impact of antidepressant treatment. Archives of Medical Research 38, 247–252.
H Herken , E Uz , H Ozyurt , S Sogut , O Virit , O Akyol (2001). Evidence that the activities of erythrocyte free radical scavenging enzymes and the products of lipid peroxidation are increased in different forms of schizophrenia. Molecular Psychiatry 6, 66–73.
I Hovatta , RS Tennant , R Helton , RA Marr , O Singer , JM Redwine , JA Ellison , EE Schadt , IM Verma , DJ Lockhart , C Barlow (2005). Glyoxalase 1 and glutathione reductase 1 regulate anxiety in mice. Nature 438, 662–666.
T Kato (2006). The role of mitochondrial dysfunction in bipolar disorder. Drug News and Perspectives 19, 597–602.
T Kato (2007). Mitochondrial dysfunction as the molecular basis of bipolar disorder: therapeutic implications. CNS Drugs 21, 1–11.
MM Khan , DR Evans , V Gunna , RE Scheffer , VV Parikh , SP Mahadik (2002). Reduced erythrocyte membrane essential fatty acids and increased lipid peroxides in schizophrenia at the never-medicated first-episode of psychosis and after years of treatment with antipsychotics. Schizophrenia Research 58, 1–10.
SD Khanzode , GN Dakhale , SS Khanzode , A Saoji , R Palasodkar (2003). Oxidative damage and major depression: the potential antioxidant action of selective serotonin re-uptake inhibitors. Redox Report 8, 365–370.
X Khawaja , J Xu , JJ Liang , JE Barrett (2004). Proteomic analysis of protein changes developing in rat hippocampus after chronic antidepressant treatment: Implications for depressive disorders and future therapies. Journal of Neuroscience Research 75, 451–460.
NG Kolosova , NA Trofimova , A Fursova (2006). Opposite effects of antioxidants on anxiety in Wistar and OXYS rats. Bulletin of Experimental Biology and Medicine 141, 734–737.
P Kovacic (2005). Unifying mechanism for addiction and toxicity of abused drugs with application to dopamine and glutamate mediators: electron transfer and reactive oxygen species. Medical Hypotheses 65, 90–96.
P Kovacic , AL Cooksy (2005). Unifying mechanism for toxicity and addiction by abused drugs: electron transfer and reactive oxygen species. Medical Hypotheses 64, 357–366.
S Kropp , V Kern , K Lange , D Degner , G Hajak , J Kornhuber , E Ruther , HM Emrich , U Schneider , S Bleich (2005). Oxidative stress during treatment with first- and second-generation antipsychotics. Journal of Neuropsychiatry and Clinical Neurosciences 17, 227–231.
M Kuloglu , M Atmaca , E Tezcan , O Gecici , H Tunckol , B Ustundag (2002a). Antioxidant enzyme activities and malondialdehyde levels in patients with obsessive-compulsive disorder. Neuropsychobiology 46, 27–32.
M Kuloglu , M Atmaca , E Tezcan , B Ustundag , S Bulut (2002b). Antioxidant enzyme and malondialdehyde levels in patients with panic disorder. Neuropsychobiology 46, 186–189.
M Kuloglu , B Ustundag , M Atmaca , H Canatan , AE Tezcan , N Cinkilinc (2002c). Lipid peroxidation and antioxidant enzyme levels in patients with schizophrenia and bipolar disorder. Cell Biochemistry and Function 20, 171–175.
JS Lai , C Zhao , JJ Warsh , PP Li (2006). Cytoprotection by lithium and valproate varies between cell types and cellular stresses. European Journal of Pharmacology 539, 18–26.
R Landgraf , MS Kessler , M Bunck , C Murgatroyd , D Spengler , M Zimbelmann , M Nussbaumer , L Czibere , CW Turck , N Singewald , D Rujescu , E Frank (2007). Candidate genes of anxiety-related behavior in HAB/LAB rats and mice: focus on vasopressin and glyoxalase-I. Neuroscience and Biobehavioural Reviews 31, 89–102.
SD LaRowe , P Mardikian , R Malcolm , H Myrick , P Kalivas , K McFarland , M Saladin , A McRae , K Brady (2006). Safety and tolerability of N-acetylcysteine in cocaine-dependent individuals. American Journal on Addictions 15, 105–110.
SD LaRowe , H Myrick , S Hedden , P Mardikian , M Saladin , A McRae , K Brady , PW Kalivas , R Malcolm (2007). Is cocaine desire reduced by N-acetylcysteine? American Journal of Psychiatry 164, 1115–1117.
CS Lee , ES Han , WB Lee (2003). Antioxidant effect of phenelzine on MPP+-induced cell viability loss in differentiated PC12 cells. Neurochemical Research 28, 1833–1841.
HC Li , QZ Chen , Y Ma , JF Zhou (2006). Imbalanced free radicals and antioxidant defense systems in schizophrenia: a comparative study. Journal of Zhejiang University. Science B 7, 1981–986.
JM Looney , HM Childs (1934). The lactic acid and glutathione content of the blood of schizophrenic patients. Journal of Clinical Investigation 13, 963–968.
R Machado-Vieira , AC Andreazza , CI Viale , V Zanatto , V Cereser Jr., R da Silva Vargas , F Kapczinski , LV Portela , DO Souza , M Salvador , V Gentil (2007). Oxidative stress parameters in unmedicated and treated bipolar subjects during initial manic episode: a possible role for lithium antioxidant effects. Neurosci Letters 421, 33–36.
M Maes , N De Vos , R Pioli , P Demedts , A Wauters , H Neels , A Christophe (2000). Lower serum vitamin E concentrations in major depression. Another marker of lowered antioxidant defenses in that illness. Journal of Affective Disorders 58, 241–246.
SP Mahadik , S Mukherjee , R Scheffer , EE Correnti , JS Mahadik (1998). Elevated plasma lipid peroxides at the onset of nonaffective psychosis. Biological Psychiatry 43, 674–679.
RM Marchbanks , M Ryan , IN Day , M Owen , P McGuffin , SA Whatley (2003). A mitochondrial DNA sequence variant associated with schizophrenia and oxidative stress. Schizophrenia Research 65, 33–38.
A McQuillin , NJ Bass , G Kalsi , J Lawrence , V Puri , K Choudhury , SD Detera-Wadleigh , D Curtis , HM Gurling (2006). Fine mapping of a susceptibility locus for bipolar and genetically related unipolar affective disorders, to a region containing the C21ORF29 and TRPM2 genes on chromosome 21q22.3. Molecular Psychiatry 11, 134–142.
JL Mehta , N Rasouli , AK Sinha , B Molavi (2006). Oxidative stress in diabetes: a mechanistic overview of its effects on atherogenesis and myocardial dysfunction. International Journal of Biochemistry and Cell Biology 38, 794–803.
TM Michel , J Thome , D Martin , K Nara , S Zwerina , T Tatschner , HG Weijers , E Koutsilieri (2004). Cu, Zn- and Mn-superoxide dismutase levels in brains of patients with schizophrenic psychosis. Journal of Neural Transmission 111, 1191–1201.
CS Miller (1999). Are we on the threshold of a new theory of disease? Toxicant-induced loss of tolerance and its relationship to addiction and abdiction. Toxicology and Industrial Health 15, 284–294.
X Ming , TP Stein , M Brimacombe , WG Johnson , GH Lambert , GC Wagner (2005). Increased excretion of a lipid peroxidation biomarker in autism. Prostaglandins, Leukotrienes, and Essential Fatty Acids 73, 379–384.
N Nishioka , SE Arnold (2004). Evidence for oxidative DNA damage in the hippocampus of elderly patients with chronic schizophrenia. American Journal of Geriatric Psychiatry 12, 167–175.
BL Odlaug , JE Grant (2007). N-acetyl cysteine in the treatment of grooming disorders. Journal of Clinical Psychopharmacology 27, 227–229.
AJ Owen , MJ Batterham , YC Probst , BF Grenyer , LC Tapsell (2005). Low plasma vitamin E levels in major depression: diet or disease? European Journal of Clinical Nutrition 59, 304–306.
ME Ozcan , M Gulec , E Ozerol , R Polat , O Akyol (2004). Antioxidant enzyme activities and oxidative stress in affective disorders. International Clinical Psychopharmacology 19, 89–95.
P Pacher , JS Beckman , L Liaudet (2007). Nitric oxide and peroxynitrite in health and disease. Physiological Reviews 87, 315–424.
SN Pal , PC Dandiya (1994). Glutathione as a cerebral substrate in depressive behavior. Pharmacology, Biochemisty, and Behavior 48, 845–851.
ML Pall , JD Satterlee (2001). Elevated nitric oxide/peroxynitrite mechanism for the common etiology of multiple chemical sensitivity, chronic fatigue syndrome, and posttraumatic stress disorder. Annals of the New York Academy of Sciences 933, 323–329.
J Pan , Q Zhang , Y Zhang , Z Ouyang , Q Zheng , R Zheng (2005). Oxidative stress in heroin administered mice and natural antioxidants protection. Life Sciences 77, 183–193.
V Parikh , MM Khan , SP Mahadik (2003). Differential effects of antipsychotics on expression of antioxidant enzymes and membrane lipid peroxidation in rat brain. Journal of Psychiatric Research 37, 43–51.
M Peet , B Murphy , J Shay , D Horrobin (1998). Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients. Biological Psychiatry 43, 315–319.
FC Peng , SH Tang , MC Huang , CC Chen , TL Kuo , SJ Yin (2005). Oxidative status in patients with alcohol dependence: a clinical study in Taiwan. Journal of Toxicology and Environmental Health, Part A 68, 1497–1509.
S Penugonda , S Mare , G Goldstein , WA Banks , N Ercal (2005). Effects of N-acetylcysteine amide (NACA), a novel thiol antioxidant against glutamate-induced cytotoxicity in neuronal cell line PC12. Brain Research 1056, 132–138.
S Petruzzelli , LM Tavanti , N Pulera , E Fornai , R Puntoni , A Celi , C Giuntini (2000). Effects of nicotine replacement therapy on markers of oxidative stress in cigarette smokers enrolled in a smoking cessation program. Nicotine and Tobacco Research 2, 345–350.
A Pillai , V Parikh , AV Terry Jr., SP Mahadik (2007). Long-term antipsychotic treatments and crossover studies in rats: differential effects of typical and atypical agents on the expression of antioxidant enzymes and membrane lipid peroxidation in rat brain. Journal of Psychiatric Research 41, 372–386.
S Prabakaran , JE Swatton , MM Ryan , SJ Huffaker , JT Huang , JL Griffin , M Wayland , T Freeman , F Dudbridge , KS Lilley , (2004). Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress. Molecular Psychiatry 9, 684–697, 643.
D Psimadas , N Messini-Nikolaki , M Zafiropoulou , A Fortos , S Tsilimigaki , SM Piperakis (2004). DNA damage and repair efficiency in lymphocytes from schizophrenic patients. Cancer Letters 204, 33–40.
J Ramirez , R Garnica , MC Boll , S Montes , C Rios (2004). Low concentration of nitrite and nitrate in the cerebrospinal fluid from schizophrenic patients: a pilot study. Schizophrenia Research 68, 357–361.
PK Ranjekar , A Hinge , MV Hegde , M Ghate , A Kale , S Sitasawad , UV Wagh , VB Debsikdar , SP Mahadik (2003). Decreased antioxidant enzymes and membrane essential polyunsaturated fatty acids in schizophrenic and bipolar mood disorder patients. Psychiatry Research 121, 109–122.
R Reddy , M Keshavan , JK Yao (2003). Reduced plasma antioxidants in first-episode patients with schizophrenia. Schizophrenia Research 62, 205–212.
R Rodrigo , C Guichard , R Charles (2007). Clinical pharmacology and therapeutic use of antioxidant vitamins. Fundamental and Clinical Pharmacology 21, 111–127.
M Saadat , F Mobayen , H Farrashbandi (2007). Genetic polymorphism of glutathione S-transferase T1: A candidate genetic modifier of individual susceptibility to schizophrenia. Psychiatry Research 153, 87–91.
TA Sarafian , JA Magallanes , H Shau , D Tashkin , MD Roth (1999). Oxidative stress produced by marijuana smoke. An adverse effect enhanced by cannabinoids. American Journal of Respiratory Cell and Molecular Biology 20, 1286–1293.
A Sarandol , S Kirli , C Akkaya , A Altin , M Demirci , E Sarandol (2007a). Oxidative-antioxidative systems and their relation with serum S100 B levels in patients with schizophrenia: Effects of short term antipsychotic treatment. Progress in Neuropsychopharmacology and Biological Psychiatry 31, 1164–1169.
A Sarandol , E Sarandol , SS Eker , S Erdinc , E Vatansever , S Kirli (2007b). Major depressive disorder is accompanied with oxidative stress: short-term antidepressant treatment does not alter oxidative-antioxidative systems. Human Psychopharmacology 22, 67–73.
A Sarandol , E Sarandol , SS Eker , EU Karaagac , BZ Hizli , M Dirican , S Kirli (2006). Oxidation of apolipoprotein B-containing lipoproteins and serum paraoxonase/arylesterase activities in major depressive disorder. Progress in Neuropsychopharmacology and Biological Psychiatry 30, 1103–1108.
HA Savas , HS Gergerlioglu , F Armutcu , H Herken , HR Yilmaz , E Kocoglu , S Selek , H Tutkun , SS Zoroglu , O Akyol (2006). Elevated serum nitric oxide and superoxide dismutase in euthymic bipolar patients: impact of past episodes. World Journal of Biological Psychiatry 7, 51–55.
ML Selley (2004). Increased (E)-4-hydroxy-2-nonenal and asymmetric dimethylarginine concentrations and decreased nitric oxide concentrations in the plasma of patients with major depression. Journal of Affective Disorders 80, 249–256.
L Shao , X Sun , L Xu , LT Young , JF Wang (2006). Mood stabilizing drug lithium increases expression of endoplasmic reticulum stress proteins in primary cultured rat cerebral cortical cells. Life Sciences 78, 1317–1323.
L Shao , LT Young , JF Wang (2005). Chronic treatment with mood stabilizers lithium and valproate prevents excitotoxicity by inhibiting oxidative stress in rat cerebral cortical cells. Biological Psychiatry 58, 879–884.
YI Sheline , MH Gado , HC Kraemer (2003). Untreated depression and hippocampal volume loss. American Journal of Psychiatry 160, 1516–1518.
H Sies (1997). Oxidative stress: oxidants and antioxidants. Experimental Physiology 82, 291–295.
EY Sivrioglu , S Kirli , D Sipahioglu , B Gursoy , E Sarandol (2007). The impact of omega-3 fatty acids, vitamins E and C supplementation on treatment outcome and side effects in schizophrenia patients treated with haloperidol: an open-label pilot study. Progress in Neuropsychopharmacology and Biological Psychiatry 31, 1493–1499.
AO Skinner , SP Mahadik , DL Garver (2005). Thiobarbituric acid reactive substances in the cerebrospinal fluid in schizophrenia. Schizophrenia Research 76, 83–87.
S Sogut , SS Zoroglu , H Ozyurt , HR Yilmaz , F Ozugurlu , E Sivasli , O Yetkin , M Yanik , H Tutkun , HA Savas , M Tarakcioglu , O Akyol (2003). Changes in nitric oxide levels and antioxidant enzyme activities may have a role in the pathophysiological mechanisms involved in autism. Clinica Chimica Acta 331, 111–117.
N Srivastava , MK Barthwal , PK Dalal , AK Agarwal , D Nag , PK Seth , RC Srimal , M Dikshit (2002). A study on nitric oxide, beta-adrenergic receptors and antioxidant status in the polymorphonuclear leukocytes from the patients of depression. Journal of Affective Disorders 72, 45–52.
N Srivastava , MK Barthwal , PK Dalal , AK Agarwal , D Nag , RC Srimal , PK Seth , M Dikshit (2001). Nitrite content and antioxidant enzyme levels in the blood of schizophrenia patients. Psychopharmacology 158, 140–145.
GM Straw , LB Bigelow , DG Kirch (1989). Haloperidol and reduced haloperidol concentrations and psychiatric ratings in schizophrenic patients treated with ascorbic acid. Journal of Clinical Psychopharmacology 9, 130–132.
F Taneli , S Pirildar , F Akdeniz , BS Uyanik , Z Ari (2004). Serum nitric oxide metabolite levels and the effect of antipsychotic therapy in schizophrenia. Archives of Medical Research 35, 401–405.
MG Tansey , MK McCoy , TC Frank-Cannon (2007). Neuroinflammatory mechanisms in Parkinson's disease: Potential environmental triggers, pathways, and targets for early therapeutic intervention. Experimental Neurology 208, 1–25.
S Tenenbaum , JC Paull , EP Sparrow , DK Dodd , L Green (2002). An experimental comparison of Pycnogenol and methylphenidate in adults with Attention-Deficit/Hyperactivity Disorder (ADHD). Journal of Attention Disorders 6, 49–60.
M Tosic , J Ott , S Barral , P Bovet , P Deppen , F Gheorghita , ML Matthey , J Parnas , M Preisig , M Saraga , (2006). Schizophrenia and oxidative stress: glutamate cysteine ligase modifier as a susceptibility gene. American Journal of Human Genetics 79, 586–592.
MG Traber , J Atkinson (2007). Vitamin E, antioxidant and nothing more. Free Radical Biology and Medicine 43, 4–15.
J Trebaticka , S Kopasova , Z Hradecna , K Cinovsky , I Skodacek , J Suba , J Muchova , I Zitnanova , I Waczulikova , P Rohdewald , Z Durackova (2006). Treatment of ADHD with French maritime pine bark extract, Pycnogenol. European Child and Adolescent Psychiatry 15, 329–335.
H Tsukahara (2007). Biomarkers for oxidative stress: clinical application in pediatric medicine. Current Medicinal Chemistry 14, 339–351.
M Valko , D Leibfritz , J Moncol , MT Cronin , M Mazur , J Telser (2007). Free radicals and antioxidants in normal physiological functions and human disease. International Journal of Biochemistry and Cell Biology 39, 44–84.
TG van Erp , PA Saleh , M Huttunen , J Lonnqvist , J Kaprio , O Salonen , L Valanne , VP Poutanen , CG Standertskjold-Nordenstam , TD Cannon (2004). Hippocampal volumes in schizophrenic twins. Archives of General Psychiatry 61, 346–353.
F Van Hunsel , A Wauters , E Vandoolaeghe , H Neels , P Demedts , M Maes (1996). Lower total serum protein, albumin, and beta- and gamma-globulin in major and treatment-resistant depression: effects of antidepressant treatments. Psychiatry Research 65, 159–169.
M Verleye , R Steinschneider , FX Bernard , JM Gillardin (2007). Moclobemide attenuates anoxia and glutamate-induced neuronal damage in vitro independently of interaction with glutamate receptor subtypes. Brain Research 1138, 30–38.
M Vignes , T Maurice , F Lante , M Nedjar , K Thethi , J Guiramand , M Recasens (2006). Anxiolytic properties of green tea polyphenol (−)-epigallocatechin gallate (EGCG). Brain Research 1110, 102–115.
H Wang , H Xu , LE Dyck , XM Li (2005). Olanzapine and quetiapine protect PC12 cells from beta-amyloid peptide(25-35)-induced oxidative stress and the ensuing apoptosis. Journal of Neuroscience Research 81, 572–580.
JF Wang , JE Azzam , LT Young (2003). Valproate inhibits oxidative damage to lipid and protein in primary cultured rat cerebrocortical cells. Neuroscience 116, 485–489.
Z Wei , O Bai , JS Richardson , DD Mousseau , XM Li (2003). Olanzapine protects PC12 cells from oxidative stress induced by hydrogen peroxide. Journal of Neuroscience Research 73, 364–368.
M Yanik , H Vural , A Kocyigit , H Tutkun , SS Zoroglu , H Herken , HA Savas , A Koylu , O Akyol (2003). Is the arginine-nitric oxide pathway involved in the pathogenesis of schizophrenia? Neuropsychobiology 47, 61–65.
M Yanik , H Vural , H Tutkun , SS Zoroglu , HA Savas , H Herken , A Kocyigit , H Keles , O Akyol (2004b). The role of the arginine-nitric oxide pathway in the pathogenesis of bipolar affective disorder. European Archives of Psychiatry and Clinical Neuroscience 254, 43–47.
JK Yao , S Leonard , R Reddy (2006a). Altered glutathione redox state in schizophrenia. Disease Markers 22, 83–93.
JK Yao , S Leonard , RD Reddy (2004). Increased nitric oxide radicals in postmortem brain from patients with schizophrenia. Schizophrenia Bulletin 30, 923–934.
JK Yao , R Reddy , LG McElhinny , DP van Kammen (1998a). Reduced status of plasma total antioxidant capacity in schizophrenia. Schizophrenia Research 32, 1–8.
JK Yao , R Reddy , DP van Kammen (1998b). Reduced level of plasma antioxidant uric acid in schizophrenia. Psychiatry Research 80, 29–39.
JK Yao , R Reddy , DP van Kammen (2000). Abnormal age-related changes of plasma antioxidant proteins in schizophrenia. Psychiatry Research 97, 137–151.
Y Yao , WJ Walsh , WR McGinnis , D Pratico (2006b). Altered vascular phenotype in autism: correlation with oxidative stress. Archives of Neurology 63, 1161–1164.
O Yorbik , A Sayal , C Akay , DI Akbiyik , T Sohmen (2002). Investigation of antioxidant enzymes in children with autistic disorder. Prostaglandins, Leukotrienes, and Essential Fatty Acids 67, 341–343.
J Young , SB McKinney , BM Ross , KW Wahle , SP Boyle (2007). Biomarkers of oxidative stress in schizophrenic and control subjects. Prostaglandins, Leukotrienes, and Essential Fatty Acids 76, 73–85.
XY Zhang , YL Tan , LY Cao , GY Wu , Q Xu , Y Shen , DF Zhou (2006a). Antioxidant enzymes and lipid peroxidation in different forms of schizophrenia treated with typical and atypical antipsychotics. Schizophrenia Research 81, 291–300.
XY Zhang , DF Zhou , LY Cao , GY Wu (2006b). The effects of Ginkgo biloba extract added to haloperidol on peripheral T cell subsets in drug-free schizophrenia: a double-blind, placebo-controlled trial. Psychopharmacology 188, 12–17.
XY Zhang , DF Zhou , LY Cao , PY Zhang , GY Wu , YC Shen (2003). The effect of risperidone treatment on superoxide dismutase in schizophrenia. Journal of Clinical Psychopharmacology 23, 128–131.
XY Zhang , DF Zhou , JM Su , PY Zhang (2001a). The effect of extract of ginkgo biloba added to haloperidol on superoxide dismutase in inpatients with chronic schizophrenia. Journal of Clinical Psychopharmacology 21, 85–88.
XY Zhang , DF Zhou , PY Zhang , GY Wu , JM Su , LY Cao (2001b). A double-blind, placebo-controlled trial of extract of Ginkgo biloba added to haloperidol in treatment-resistant patients with schizophrenia. Journal of Clinical Psychiatry 62, 878–883.
JM Zingg , A Azzi (2004). Non-antioxidant activities of vitamin E. Current Medicinal Chemistry 11, 1113–1133.
SS Zoroglu , F Armutcu , S Ozen , A Gurel , E Sivasli , O Yetkin , I Meram (2004). Increased oxidative stress and altered activities of erythrocyte free radical scavenging enzymes in autism. European Archives of Psychiatry and Clinical Neuroscience 254, 143–147.
SS Zoroglu , H Herken , M Yurekli , E Uz , H Tutkun , HA Savas , C Bagci , ME Ozen , B Cengiz , EA Cakmak , MI Dogru , O Akyol (2002). The possible pathophysiological role of plasma nitric oxide and adrenomedullin in schizophrenia. Journal of Psychiatric Research 36, 309–315.